Literature DB >> 19129997

Association between p53 codon 72 genetic polymorphism and tobacco use and lung cancer risk.

Dante D Cáceres1, Luis A Quiñones, Jane C Schroeder, Leonel D Gil, Carlos E Irarrázabal.   

Abstract

Lung cancer (LCa) is the leading cause of death by cancer in men. Genetic and environmental factors play a synergistic role in its etiology. We explore in 111 lung cancer cases and 133 unrelated noncancer controls the gene-environment interaction (G x E) between p53cd72 polymorphism variants and smoking and the effect on LCa risk in two kinds of case-control designs. We assessed the interaction odds ratio (IOR) using an adjusted unconditional logistic model. We found a significant and positive interaction association between Pro* allele carriers and smoking habits in both case-control and case-only designs: IOR = 3.90 (95% confidence interval [CI] = 1.10-13.81) and 3.05 (95% CI = 1.63-5.72), respectively. These exploratory results suggest a synergistic effect of the smoking habit and the susceptibility of the Pro allele on lung cancer risk compared with each risk factor alone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129997     DOI: 10.1007/s00408-008-9133-3

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  38 in total

1.  Low P-values or narrow confidence intervals: which are more durable?

Authors:  C Poole
Journal:  Epidemiology       Date:  2001-05       Impact factor: 4.822

2.  Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene diol epoxide in vitro: role of reactive oxygen and biological selection.

Authors:  Yu-Min Shen; Andrea B Troxel; Srilakshmi Vedantam; Trevor M Penning; Jeffrey Field
Journal:  Chem Res Toxicol       Date:  2006-11       Impact factor: 3.739

3.  MspI polymorphism of the human p53 gene.

Authors:  O de la Calle-Martín; M Romero; V Fabregat; G Ercilla; J Vives; J Yagüe
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

4.  Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.

Authors:  J To-Figueras; M Gene; J Gomez-Catalan; C Galan; J Firvida; M Fuentes; M Rodamilans; E Huguet; J Estape; J Corbella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-05       Impact factor: 4.254

Review 5.  Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer.

Authors:  W P Bennett; S P Hussain; K H Vahakangas; M A Khan; P G Shields; C C Harris
Journal:  J Pathol       Date:  1999-01       Impact factor: 7.996

Review 6.  On the origin of G --> T transversions in lung cancer.

Authors:  Gerd P Pfeifer; Pierre Hainaut
Journal:  Mutat Res       Date:  2003-05-15       Impact factor: 2.433

7.  P53 polymorphisms and haplotypes in lung cancer.

Authors:  R Birgander; A Själander; A Rannug; A K Alexandrie; M I Sundberg; J Seidegård; G Tornling; G Beckman; L Beckman
Journal:  Carcinogenesis       Date:  1995-09       Impact factor: 4.944

8.  Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer.

Authors:  K Kawajiri; K Nakachi; K Imai; J Watanabe; S Hayashi
Journal:  Carcinogenesis       Date:  1993-06       Impact factor: 4.944

9.  Allelic frequency of a p53 polymorphism in human lung cancer.

Authors:  A Weston; L S Perrin; K Forrester; R N Hoover; B F Trump; C C Harris; N E Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1992 Sep-Oct       Impact factor: 4.254

10.  p53 regulates cellular responses to environmental carcinogen benzo[a]pyrene-7,8-diol-9,10-epoxide in human lung cancer cells.

Authors:  Hui Xiao; Shivendra V Singh
Journal:  Cell Cycle       Date:  2007-05-14       Impact factor: 4.534

View more
  10 in total

1.  Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.

Authors:  Xiang-Hua Ye; Zhi-Bin Bu; Jie Feng; Ling Peng; Xin-Biao Liao; Xin-Li Zhu; Xiao-Li Sun; Hao-Gang Yu; Dan-Fang Yan; Sen-Xiang Yan
Journal:  Mol Biol Rep       Date:  2013-11-23       Impact factor: 2.316

Review 2.  The association between TP53 Arg72Pro polymorphism and lung cancer susceptibility: evidence from 30,038 subjects.

Authors:  Qian Qiao; Weiguo Hu
Journal:  Lung       Date:  2013-04-18       Impact factor: 2.584

3.  Polymorphisms in TP53 and MDM2 contribute to higher risk of colorectal cancer in Chinese population: a hospital-based, case-control study.

Authors:  Yuxing Zhang; Li Liu; Yingchun Tang; Chao Chen; Qian Wang; Jun Xu; Chao Yang; Xiaoping Miao; Sheng Wei; Jigui Chen; Shaofa Nie
Journal:  Mol Biol Rep       Date:  2012-06-29       Impact factor: 2.316

4.  Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.

Authors:  Ankita Kumari; Charu Bahl; Navneet Singh; Digambar Behera; Siddharth Sharma
Journal:  Mol Biol Rep       Date:  2016-09-10       Impact factor: 2.316

5.  Association between p53 codon 72 genetic polymorphisms and tobacco use and lung cancer risk in a Chinese population.

Authors:  Dazhong Liu; Fei Wang; Xiaotong Guo; Qiushi Wang; Wei Wang; Hao Xu; Guangquan Xu
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

6.  P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects.

Authors:  Chao Zhou; Hao Chen; An Wang
Journal:  Tumour Biol       Date:  2013-05-30

7.  Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.

Authors:  Md Shaki Mostaid; Maizbha Uddin Ahmed; Mohammad Safiqul Islam; Muhammad Shahdaat Bin Sayeed; Abul Hasnat
Journal:  Tumour Biol       Date:  2014-07-18

8.  Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.

Authors:  Keith R Loeb; Maryam M Asgari; Stephen E Hawes; Qinghua Feng; Joshua E Stern; Mingjun Jiang; Zsolt B Argenyi; Ethel-Michele de Villiers; Nancy B Kiviat
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

9.  TP53 R72P Polymorphism and Susceptibility to Human Papillomavirus Infection Among Women With Human Immunodeficiency Virus in Morocco: A Case-control Study.

Authors:  Ahd Oulad Lahsen; Hanâ Baba; Rajaa Bensghir; Naouar Fayssel; Mustapha Sodqi; Latifa Marih; Sellama Nadifi; Lahcen Wakrim; Kamal Marhoum El Filali; Sayeh Ezzikouri
Journal:  J Cancer Prev       Date:  2017-12-30

Review 10.  State of Art of Cancer Pharmacogenomics in Latin American Populations.

Authors:  Andrés López-Cortés; Santiago Guerrero; María Ana Redal; Angel Tito Alvarado; Luis Abel Quiñones
Journal:  Int J Mol Sci       Date:  2017-05-23       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.